Concepedia

Chengzhi Lu

CL

Statistics

Publications

9

Citations

192

H-Index

9

Active since

2013

Affiliations

Tianjin Medical University(Current)

Tianjin First Center Hospital

Nankai University

Chengzhi Lu is an author at Tianjin Medical University specializing in medicine, cardiovascular disease, and chronic kidney disease.

ORCID

Top concepts

Publications per year

2013–2023

9

Publications

9

A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment

Runze Zhao, Xiaoyue Ning, Mengqi Wang et al. · ACS Applied Materials & Interfaces · 2022 · 46 citations

, , +21

Targeting mitochondria-inflammation circle by renal denervation reduces atheroprone endothelial phenotypes and atherosclerosis

Zhuqing Li, Qi Li, Li Wang et al. · Redox Biology · 2021 · 38 citations · Full text

[The effect of catheter based renal synthetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension].

Li Wang, Chengzhi Lu, Xin Zhang et al. · PubMed · 2013 · 20 citations

Galectin-3 inhibition attenuates doxorubicin-induced cardiac dysfunction by upregulating the expression of peroxiredoxin-4

Yunpeng Tian, Wei Lv, Chengzhi Lu et al. · Canadian Journal of Physiology and Pharmacology · 2020 · 19 citations

Maslinic Acid Attenuates Ischemia/Reperfusion Injury-Induced Myocardial Inflammation and Apoptosis by Regulating HMGB1-TLR4 Axis

Qi Li, Mengping Xu, Zhuqing Li et al. · Frontiers in Cardiovascular Medicine · 2021 · 19 citations · Full text

1–5 of 9